Current Volume 8
Abstract
The first evidence of severe acute respiratory syndrome corona virus-2 (SARS CoV-2) was traced in Wuhan city, China, in December2019. The global outbreak of the novel coronavirus surpassed in early 2020. Because of the mutation of coronavirus, a large number of mutated strains have been observed in various countries. WHO designated the most important and rapid spreading variants as alpha, beta, gamma, delta, and omicron. The rapid clinical trial of several drugs has been started since early 2019 for the treatment of patients infected by the novel coronavirus. At the beginning of the pandemic, some drugs such as chloroquine and hydroxychloroquine were recommended for treatment of the covid-19 patients without any adequate clinical trials. The drugs used for the treatment of coronavirus infection can be divided into protocol drugs and non-protocol drugs. Here, the efficacy of several protocol and non-protocoldrugs towards the prevention and treatment of coronavirus infection, their interaction with coronavirus, and side effects of such recommended drugs are described in this chapter.
Citations
IRE Journals:
Pankaj Sarkar
"Use of COVID-19 Drugs: A Brief Review on Indian Perspective" Iconic Research And Engineering Journals Volume 6 Issue 2 2022 Page 24-31
IEEE:
Pankaj Sarkar
"Use of COVID-19 Drugs: A Brief Review on Indian Perspective" Iconic Research And Engineering Journals, 6(2)
About IRE Journals
IRE Journals is an open access online journals established with an aim to publish high quality of research work in various diciplines. We have more than 6 years in publications. Over 2500+ papers already published.
Important Links
For Authors
Volume 7:
Issue 1, Issue 2, Issue 3, Issue 4, Issue 5, Issue 6, Issue 7, Issue 8, Issue 9, Issue 10, Issue 11Volume 6:
Issue 1, Issue 2, Issue 3, Issue 4, Issue 5, Issue 6, Issue 7, Issue 8, Issue 9, Issue 10, Issue 11, Issue 12Volume 5:
Issue 1, Issue 2, Issue 3, Issue 4, Issue 5, Issue 6, Issue 7, Issue 8, Issue 9, Issue 10, Issue 11, Issue 12Volume 4:
Issue 1, Issue 2, Issue 3, Issue 4, Issue 5, Issue 6, Issue 7, Issue 8, Issue 9, Issue 10, Issue 11, Issue 12Volume 3:
Issue 1, Issue 2, Issue 3, Issue 4, Issue 5, Issue 6, Issue 7, Issue 8, Issue 9, Issue 10, Issue 11, Issue 12